735. Severity and Healthcare Costs of Respiratory Syncytial Virus Hospitalizations in US Preterm Infants Born at 29–34 Weeks Gestation: 2014–2016

BACKGROUND: In 2014, the American Academy of Pediatrics recommended against the use of respiratory syncytial virus (RSV) immunoprophylaxis in infants 29–34 weeks gestational age (wGA) at birth without chronic lung disease/bronchopulmonary dysplasia (CLD/BPD) or congenital heart disease (CHD). To inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Mitchell, Krilov, Leonard R, Fergie, Jaime, Ambrose, Christopher S, Wade, Sally, Kong, Amanda, Brannman, Lance
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253181/
http://dx.doi.org/10.1093/ofid/ofy210.742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253181/
http://dx.doi.org/10.1093/ofid/ofy210.742

Ejemplares similares